Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CK.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.56.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.56.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.56.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.13.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.13.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.13.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CK.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CK.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.1.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.11.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.11.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.11.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDLNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDLNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDLNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.29.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.29.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.29.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.29.2 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
AY.29.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.29.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
BC.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BC.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.10.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.10.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used